Enhancement of lymphokine-activated killer cell cytotoxicity implicated by surface adhesion molecule expression on tumor cell lines pretreated with anti-cancer agents.
Ishihata
R
R
Second Department of Internal Medicine, Fukushima Medical College, Japan.
Okubo
M
M
Kasukawa
R
R
D015703:Antigens, CD / Q000096:biosynthesis; D000970:Antineoplastic Agents / Q000494:pharmacology*; D018968:CD58 Antigens; D015815:Cell Adhesion Molecules / Q000096:biosynthesis*; D002945:Cisplatin / Q000494:pharmacology; D003131:Combined Modality Therapy; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis; D015979:Killer Cells, Lymphokine-Activated / Q000187:drug effects*; D008562:Membrane Glycoproteins / Q000096:biosynthesis; D016685:Mitomycin / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000276:immunology*
D015703:Antigens, CD; D000970:Antineoplastic Agents; D018968:CD58 Antigens; D015815:Cell Adhesion Molecules; D008562:Membrane Glycoproteins; D018799:Intercellular Adhesion Molecule-1; D016685:Mitomycin; D002945:Cisplatin